LTFS
GTHX

Ladenburg Thalmann Financial Services’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$93K Sell
3,536
-200
-5% -$4.68K ﹤0.01% 3081
2019
Q3 		$85K Buy
3,736
+570
+18% +$18K ﹤0.01% 3052
2019
Q2 		$97K Buy
3,166
+500
+19% +$10.5K ﹤0.01% 2989
2019
Q1 		$44K Hold
2,666
– – ﹤0.01% 3499
2018
Q4 		$51K Sell
2,666
-100
-4% -$3.75K ﹤0.01% 3235
2018
Q3 		$145K Sell
2,766
-1,134
-29% -$61.8K ﹤0.01% 2556
2018
Q2 		$144K Hold
3,900
– – ﹤0.01% 2484
2018
Q1 		$144K Buy
3,900
+1,200
+44% +$32K ﹤0.01% 2484
2017
Q4 		$54K Buy
2,700
+400
+17% +$8.6K ﹤0.01% 3166
2017
Q3 		$57K Buy
+2,300
New +$42.5K ﹤0.01% 2997

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GTHX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its G1 Therapeutics, Inc. Common Stock (GTHX) stake by 5.4% in Q4 2019, selling an estimated $4.68K and leaving 3,536 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #3081.

Ladenburg Thalmann Financial Services first reported a position in GTHX in Q3 2017 and has held it in 10 quarters since. The position peaked at $145K in Q3 2018. 98 funds tracked by Wall St. Rank hold GTHX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3,536 shares of G1 Therapeutics, Inc. Common Stock worth $93K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 200 G1 Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $4.68K.
  • G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3081 holding.
  • Ladenburg Thalmann Financial Services first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2017 and has held it in 10 quarters since.
  • Ladenburg Thalmann Financial Services's G1 Therapeutics, Inc. Common Stock position peaked at $145K in Q3 2018.
  • 98 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.